MJ210
Product Specifications
Target
NF-κB, Reactive Oxygen Species, p38 MAPK, ROS
Related Pathways
MAPK, Metabolism, NF-κB, Immunology/Inflammation
Bioactivity
MJ210 is an orally active and blood-brain barrier-permeable modulator of the NF-κB and MAPK pathways, exhibiting neuroprotective properties. In vitro, 5 μM MJ210 can increase the survival rate of rotenone-treated SH-SY5Y cells to 81.9% and reduce levels of ROS. In vivo, 5 mg/kg MJ210 improves motor dysfunction in rat models of Parkinson's disease. MJ210 is useful for research in neurological disorders, including Parkinson's disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
AS10 1235 1 mg
Rabbit anti-Mouse IgG (H&L), ALP conjugated, min, cross-reactivity to human serum
Sign In for Pricing
View Details 
MBS9020058-01 0.02 mg (Mammalian-Cell)
Recombinant Human Interleukin-15 (IL15), Biotinylated
Sign In for Pricing
View Details MBS9020058-02 0.1 mg (Mammalian-Cell)
Recombinant Human Interleukin-15 (IL15), Biotinylated
Sign In for Pricing
View Details MBS9020058-03 1 mg (Mammalian-Cell)
Recombinant Human Interleukin-15 (IL15), Biotinylated
Sign In for Pricing
View Details